MedPath

Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center

Not Applicable
Completed
Conditions
Corneal Ulcer
Keratitis
Registration Number
NCT02293876
Lead Sponsor
Hospital Risoleta Tolentino Neves
Brief Summary

The purpose of the study is find out the better measure to achieve corneal protection in an Intensive Care Unit.

Detailed Description

Critically ill patients are at higher risk for corneal injury and the mechanisms responsible for ocular lubrication and protection can be compromised. However, the literature diverges on which is the best clinical practice for treatment. There is a scale for assessing the risk for corneal injury. Thus, the general objective of this study was to evaluate the risk for developing corneal injury in critically ill patients and the effectiveness of three types of interventions: eye gel, eyedrops and polyethylene film, compared to the control group in its prevention. The specific objectives were: verify the most effective intervention for the prevention of corneal injury from the available literature and provided by: eye gel, eyedrops and polyethylene film compared to the control group who received eye care through randomized controlled clinical trial. Patients and methods: This study was a randomized controlled trial to determine the best care for the prevention of corneal injury from those available on the market (eye drops, eye gel and polyethylene film), compared to a control group (eye care) in the period from 09/07/2013 to 03/15/2014 .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
360
Inclusion Criteria
  • Ramsay sedation scale 5 or 6
  • Glasgow coma scale lower than 7
  • Use of oxygen therapy by facial device above 6 liters per minute or mechanical ventilation
  • Blink reflex less than 5 times per minute or ocular globe exposure
Exclusion Criteria
  • Less than 48 hours in Intensive Care Unit

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
KeratitisFive days

Presence of keratitis visible with a cobalt light ophthalmoscope and fluorescein eye drop.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Risoleta Tolentino Neves

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

Hospital Risoleta Tolentino Neves
🇧🇷Belo Horizonte, Minas Gerais, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.